These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10508435)

  • 21. A new therapeutic approach in Parkinson's disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents.
    Laddha SS; Bhatnagar SP
    Bioorg Med Chem; 2009 Oct; 17(19):6796-802. PubMed ID: 19744861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-(3-ethylphenyl)-2-substituted hydrazino-3H-quinazolin-4-one derivatives: new class of analgesic and anti-inflammatory agents.
    Alagarsamy V; Raja Solomon V; Sheorey RV; Jayakumar R
    Chem Biol Drug Des; 2009 Apr; 73(4):471-9. PubMed ID: 19291107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KF24345, an adenosine uptake inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production and leukopenia via endogenous adenosine in mice.
    Noji T; Takayama M; Mizutani M; Okamura Y; Takai H; Karasawa A; Kusaka H
    J Pharmacol Exp Ther; 2002 Jan; 300(1):200-5. PubMed ID: 11752117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships of 6-fluoroquinazolines: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.
    Tobe M; Isobe Y; Tomizawa H; Nagasaki T; Obara F; Hayashi H
    Bioorg Med Chem; 2003 Feb; 11(4):609-16. PubMed ID: 12538026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Rewcastle GW; Palmer BD; Bridges AJ; Showalter HD; Sun L; Nelson J; McMichael A; Kraker AJ; Fry DW; Denny WA
    J Med Chem; 1996 Feb; 39(4):918-28. PubMed ID: 8632415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, Synthesis and Anti-inflammatory Activity of Derivatives 10-R-3-Aryl-6,7-dihydro-2H-[1,2,4] triazino[2,3-c]quinazolin-2-ones of Spiro-fused Cyclic Frameworks.
    Kolomoets O; Voskoboynik О; Antypenko O; Berest G; Nosulenko I; Palchikov V; Karpenko O; Kovalenko S
    Acta Chim Slov; 2017 Dec; 64(4):902-910. PubMed ID: 29318300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model.
    Yang F; de Villiers WJ; McClain CJ; Varilek GW
    J Nutr; 1998 Dec; 128(12):2334-40. PubMed ID: 9868178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
    Shim DW; Shin HJ; Han JW; Ji YE; Jang CH; Koppula S; Kang TB; Lee KH
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):227-35. PubMed ID: 25689174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on quinazolines. 5. 2,3-dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective alpha 1-adrenoceptor antagonists and antihypertensive agents.
    Chern JW; Tao PL; Yen MH; Lu GY; Shiau CY; Lai YJ; Chien SL; Chan CH
    J Med Chem; 1993 Jul; 36(15):2196-207. PubMed ID: 8101878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new three-component reaction: green synthesis of novel isoindolo[2,1-a]quinazoline derivatives as potent inhibitors of TNF-α.
    Kumar KS; Kumar PM; Kumar KA; Sreenivasulu M; Jafar AA; Rambabu D; Krishna GR; Reddy CM; Kapavarapu R; Shivakumar K; Priya KK; Parsa KV; Pal M
    Chem Commun (Camb); 2011 May; 47(17):5010-2. PubMed ID: 21445417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships of quinazoline derivatives: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.
    Tobe M; Isobe Y; Tomizawa H; Matsumoto M; Obara F; Nagasaki T; Hayashi H
    Bioorg Med Chem Lett; 2001 Feb; 11(4):545-8. PubMed ID: 11229767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists.
    Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK
    J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.
    Griswold DE; Webb EF; Badger AM; Gorycki PD; Levandoski PA; Barnette MA; Grous M; Christensen S; Torphy TJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):705-11. PubMed ID: 9808700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Biological Evaluation of Novel 2-(4-acetyl-3-methyl- 5-(arylamino) thiophen-2-yl)-3-arylquinazolin-4(3H)-one Derivatives as Potential Anti-inflammatory and Antioxidant Agents.
    Chaudhari PS; Chitlange SS; Nanda RK
    Antiinflamm Antiallergy Agents Med Chem; 2018; 17(2):102-114. PubMed ID: 30198442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic Fluororutaecarpine Inhibits Inflammatory Stimuli and Activates Endothelial Transient Receptor Potential Vanilloid-Type 1.
    Lee CM; Gu JA; Rau TG; Wang C; Yen CH; Huang SH; Lin FY; Lin CM; Huang ST
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28422079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.
    Corral LG; Muller GW; Moreira AL; Chen Y; Wu M; Stirling D; Kaplan G
    Mol Med; 1996 Jul; 2(4):506-15. PubMed ID: 8827720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors.
    Barlaam B; Bird TG; Lambert-Van Der Brempt C; Campbell D; Foster SJ; Maciewicz R
    J Med Chem; 1999 Nov; 42(23):4890-908. PubMed ID: 10579851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.
    Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.
    Cho NC; Cha JH; Kim H; Kwak J; Kim D; Seo SH; Shin JS; Kim T; Park KD; Lee J; No KT; Kim YK; Lee KT; Pae AN
    Bioorg Med Chem; 2015 Dec; 23(24):7717-27. PubMed ID: 26631441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiinflammatory and antiproteolytic activities of newer indolyl isoquinolines.
    Tandon M; Tandon P; Barthwal JP; Bhalla TN; Bhargava KP
    Arzneimittelforschung; 1982; 32(10):1233-5. PubMed ID: 6891221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.